Research Article

Cytokine Dysregulation in MECP2- and CDKL5-Related Rett Syndrome: Relationships with Aberrant Redox Homeostasis, Inflammation, and ω-3 PUFAs

Table 2

Relationship between clinical severity, redox status, subclinical inflammation, and circulating cytokines for the whole population: results of a stepwise multiple regression analysis.

Dependent variableFinal stepwise model adjustedMultiple correlation coefficient Residual SD-ratio Significance of value
Selected predictor variables partialP value

Clinical severity
(CCSS) [46]
(+) TNF-α0.406<0.00010.4900.476 0.6992.6635.72<0.001
(+) IL-17A0.2350.0037
(+) IL-40.362<0.0001
(−) IL-12p700.581<0.0001

Clinical severity
(CCSS) [46]
(−) GSH/GSSG0.779<0.00010.8090.805 0.8991.59220.39<0.001
(+) F4-NeuroPs0.2350.0029
(+) F2-IsoPs0.1840.0205

ESR(+) IL-17A0.319<0.00010.3040.292 0.55210.8425.38<0.001
(+) IL-4/IFN-γ0.4750.0009

P-NPBI(+) TNF-α0.532<0.00010.5630.556 0.7500.1874.79<0.001
(−) I-TAC0.358 0.0001

F2-IsoPs(+) TNF-α0.383<0.00010.5810.570 0.76212.9353.23<0.001
(+) IL-370.285 0.0018
(−) I-TAC0.434<0.0001

F2-dihomo-IsoPs(−) IL-220.596<0.00010.7110.704 0.8439.9594.52<0.001
(+) IL-4/IFN-γ0.2600.0047
(+) IL-17A0.1940.0359

F4-NeuroPs(−) IL-220.553<0.00010.8740.870 0.9352.26197.65<0.001
(+) IL-4/IFN-γ0.2470.0074
(+) IL-370.2010.0235
(−) IL-12p700.606<0.0001

IE-NPBI(+) TNF-α0.493<0.00010.4400.431 0.6640.3248.02<0.001
(−) I-TAC0.2210.0136

GSH/GSSG ratio(+) IL-220.678<0.00010.8040.797 0.8971.89117.05<0.001
(−) IL-370.2470.0076
(−) RANTES0.476<0.0001
(+) I-TAC0.684<0.0001

Plus and minus signs in brackets indicate positive or negative associations. CCSS: compressed clinical severity score [46]; ESR: erythrocyte sedimentation rate; P-NPBI: plasma non-protein-bound iron; F2-IsoPs: plasma F2-isoprostanes; F2-dihomo-IsoPs: plasma F2-dihomo-isoprostanes; F4-NeuroPs: plasma F4-neuroprostanes; IE-NBPI: intraerythrocyte non-protein-bound iron; GSH: reduced glutathione; GSSG: oxidized glutathione.